Xeris Biopharma Holdings, Inc. (0A8E)
Market Closed
1 Sep, 15:30
LSE 
$
8. 43
-0.03
-0.3546%
$
- Market Cap
- P/E Ratio
- Div Yield
270 Volume
-0.38 Eps
$ 8.46
Previous Close Want to track 0A8E and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Xeris Biopharma Holdings, Inc. (0A8E) Statistics
Valuation metrics
Market Cap 0
Enterprise value 1.63B
Trailing P/E (ttm) -87.33
Forward P/E -
PEG ratio 0.01
Price/Sales (ttm) 4.36
Price/Book (mrq) -150.56
Enterprise Value/Revenue 4.86
Enterprise Value/EBITDA 99.42
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 637
Average volume (90 days) 1.94K
Price summary
52-Week low 5.26
52-Week high 10.09
Beta -
50-Day moving average 8.41
200-Day moving average 6.92
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -0.05%
Operating margin 0.11%
Operational effectiveness
Return on assets -0.04%
Return on equity -4.26%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 1.94
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.1
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.7
Total debt (mrq) -
Total Debt/Equity (mrq) -29.74
Current ratio (mrq) 1.45%
Book value per share (mrq) -0.06
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
